Smarter Team

About the Author Smarter Team

Smarter Analyst was established to fill a gap in financial reporting for sell-side investors, where they can read exclusive reports in real time. Smarter Analyst provides coverage of equities research, unique analyst insights, and outstanding articles from knowledgeable contributors, in addition to the latest stock market news, all hand-picked by our editors.

Agile (AGRX): Should You Catch this Falling Knife?

Shares of Agile Therapeutics (AGRX), a biotech which specializes in women’s healthcare, are in a nose dive, down about 66% in the past …

JPMorgan: 3 Cheap IPO Stocks to Buy Now

The S&P 500 closed at 3,039.42 Monday evening, up 0.

Market Weekly Review: Earnings Drive Rally Ahead of FOMC

The major US stock market averages added about 1% to recent gains this week, ahead of the Fed’s next interest rate decision. Energy …

3 Buy-Rated Stocks with Over 6% Dividend Yield

How important are dividends to a stock investor’s profits? Speaking before the Financial Industry Regulatory Authority (FINRA) on October 15, 2007, investing guru …

3 Under-the-Radar Tech Stocks With Over 30% Upside

Tech stocks are doing great in 2019. According to the latest data from Fidelity Investments, year to date, tech stocks have surged 30%, …

Deutsche Bank: 3 ‘Strong Buy’ Giants to Consider Ahead of Earnings

Brexit in the UK, and a brewing border war in Syria. Missile strikes on Saudi Arabian refineries, and global warming … everywhere.

3 “Strong Buy” Oil Stocks with Over 30% Upside

Oil prices continued their near-month-long, post-September 16, post-Saudi Arabian drone attack slide on Tuesday. After falling 5.

Goldman Sachs: 3 Recession-Resistant Stocks to Buy

Less than a week ago, Goldman Sachs private wealth management chief investment officer Sharmin Mossavar-Rahmani stoked investor worries with a comment putting the …

Wall Street Loves These “Strong Buy” Dividend Stocks

Stock go up, investor happy. Stock go down, investor… sad?

3 Biotech Stocks That Could Triple in 2020

2019 has not been a great year to own biotech stocks (so far). Since the year began, the Nasdaq Biotechnology Index (NBI) is …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts